Cargando…
Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting
BACKGROUND: Current day malaria cases and deaths are indicative of a lack of access to both methods of prevention, diagnosis, and treatment; an important determinant of treatment efficacy is adherence. This study is a follow up to the baseline study of adherence to artemether-lumefantrine (AL) carri...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405916/ https://www.ncbi.nlm.nih.gov/pubmed/25888895 http://dx.doi.org/10.1186/s12936-015-0645-z |
_version_ | 1782367684151738368 |
---|---|
author | Gore-Langton, Georgia R Alenwi, Nfornuh Mungai, James Erupe, Nahashon I Eves, Katie Kimwana, Francis Njoroge Soti, David Akhwale, Willis Hassan, Farah A Juma, Elizabeth Allan, Richard |
author_facet | Gore-Langton, Georgia R Alenwi, Nfornuh Mungai, James Erupe, Nahashon I Eves, Katie Kimwana, Francis Njoroge Soti, David Akhwale, Willis Hassan, Farah A Juma, Elizabeth Allan, Richard |
author_sort | Gore-Langton, Georgia R |
collection | PubMed |
description | BACKGROUND: Current day malaria cases and deaths are indicative of a lack of access to both methods of prevention, diagnosis, and treatment; an important determinant of treatment efficacy is adherence. This study is a follow up to the baseline study of adherence to artemether-lumefantrine (AL) carried out in Garissa District in 2010. The study presented evaluates any changes in adherence levels which may have occurred in the area during this period and after nearly three years of sustained use of ACT across the public health sector. METHODS: The study was carried out in Garissa County in the North Eastern Province of Kenya and included patients fitting the suspected malaria case definition and having been prescribed AL, regardless of confirmatory diagnosis. A questionnaire assessed the intake of AL via both self-reporting by the participant and observation of blister packs by the interviewer. On separate occasions exit interviews with patients and observations of prescribers were also carried out. RESULTS: Of the 218 participants enrolled, 195 were successfully followed up. 60% of participants were found to be adherent to the three-day AL regimen, this is 4.7% lower than the proportion of participants adherent in 2010; the result of a two-sided z-test was not significant (p = 0.23). The odds of the patient being adherent to AL increased by 65% with each additional correct statement regarding how to take AL that a patient could recall (between zero and four statements), this was the only variable significantly associated with patient adherence (p = 0.01). CONCLUSION: Sustaining the ACT adherence rates at the 2010 levels, through 2.5 years of insecurity in the study area is an achievement and suggests that if security can be improved barriers to improving health service quality and patient adherence to AL would be removed. This study, by looking specifically at anti-malarial adherence over a prolonged period and in a setting of severe conflict, provides a valuable and rare insight in to the challenges and barriers to ACT adherence in such settings. |
format | Online Article Text |
id | pubmed-4405916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44059162015-04-23 Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting Gore-Langton, Georgia R Alenwi, Nfornuh Mungai, James Erupe, Nahashon I Eves, Katie Kimwana, Francis Njoroge Soti, David Akhwale, Willis Hassan, Farah A Juma, Elizabeth Allan, Richard Malar J Research BACKGROUND: Current day malaria cases and deaths are indicative of a lack of access to both methods of prevention, diagnosis, and treatment; an important determinant of treatment efficacy is adherence. This study is a follow up to the baseline study of adherence to artemether-lumefantrine (AL) carried out in Garissa District in 2010. The study presented evaluates any changes in adherence levels which may have occurred in the area during this period and after nearly three years of sustained use of ACT across the public health sector. METHODS: The study was carried out in Garissa County in the North Eastern Province of Kenya and included patients fitting the suspected malaria case definition and having been prescribed AL, regardless of confirmatory diagnosis. A questionnaire assessed the intake of AL via both self-reporting by the participant and observation of blister packs by the interviewer. On separate occasions exit interviews with patients and observations of prescribers were also carried out. RESULTS: Of the 218 participants enrolled, 195 were successfully followed up. 60% of participants were found to be adherent to the three-day AL regimen, this is 4.7% lower than the proportion of participants adherent in 2010; the result of a two-sided z-test was not significant (p = 0.23). The odds of the patient being adherent to AL increased by 65% with each additional correct statement regarding how to take AL that a patient could recall (between zero and four statements), this was the only variable significantly associated with patient adherence (p = 0.01). CONCLUSION: Sustaining the ACT adherence rates at the 2010 levels, through 2.5 years of insecurity in the study area is an achievement and suggests that if security can be improved barriers to improving health service quality and patient adherence to AL would be removed. This study, by looking specifically at anti-malarial adherence over a prolonged period and in a setting of severe conflict, provides a valuable and rare insight in to the challenges and barriers to ACT adherence in such settings. BioMed Central 2015-03-24 /pmc/articles/PMC4405916/ /pubmed/25888895 http://dx.doi.org/10.1186/s12936-015-0645-z Text en © Gore-Langton et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Gore-Langton, Georgia R Alenwi, Nfornuh Mungai, James Erupe, Nahashon I Eves, Katie Kimwana, Francis Njoroge Soti, David Akhwale, Willis Hassan, Farah A Juma, Elizabeth Allan, Richard Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting |
title | Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting |
title_full | Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting |
title_fullStr | Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting |
title_full_unstemmed | Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting |
title_short | Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting |
title_sort | patient adherence to prescribed artemisinin-based combination therapy in garissa county, kenya, after three years of health care in a conflict setting |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405916/ https://www.ncbi.nlm.nih.gov/pubmed/25888895 http://dx.doi.org/10.1186/s12936-015-0645-z |
work_keys_str_mv | AT gorelangtongeorgiar patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting AT alenwinfornuh patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting AT mungaijames patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting AT erupenahashoni patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting AT eveskatie patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting AT kimwanafrancisnjoroge patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting AT sotidavid patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting AT akhwalewillis patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting AT hassanfaraha patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting AT jumaelizabeth patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting AT allanrichard patientadherencetoprescribedartemisininbasedcombinationtherapyingarissacountykenyaafterthreeyearsofhealthcareinaconflictsetting |